This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,959.56, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price arrangement with a completion date of June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $9,254.29, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price arrangement. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,512.50, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of January 28, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $10,432.55, is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of February 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,829.39, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 21, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,294.61, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of November 20, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,044.01, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 9, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.30, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,831.71, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed price delivery order. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,245.18, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL dosage. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...